Patent US4388295A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4388295A Expired / Lapsed US ⏱️ 0.0 years remaining

Method and composition for determining human chorionic somatotropin

Assignee: Istituto Sieroterapico e Vaccinogeno Toscano Sclavo SpA
•
Filing: 1980-05-30
•
Granted: 1983-06-14
•
Expires: 2000-05-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method and an implementation are disclosed for measuring the contents of a certain component (e.g. a hormone) in a biological fluid. The basic principle of the method is that a complex is formed starting from the antagonist of the component sought for with the product of conjugation of the latter with a tracer (e.g. a radioisotope), said complex is introduced in the biological fluid to be tested and the quantity of the tracer which has been set free is measured with a measuring or dosing technique which is appropriate for the tracer which has been selected.

Inventors

  • 👤 Francesco Cocola
  • 👤 Paolo Tarli
  • 👤 Paolo Neri

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 23:32
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/58; G01N2470/00; G01N2470/10; G01N2470/12; Y; Y10; Y10S; Y10S435/00; Y10S435/967; Y10S435/97; Y10S435/975; Y10T; Y10T436/00; Y10T436/13

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 63 words
A method for quantitatively determining the presence of Human Chorionic Somatotropin (HCS) in a biological fluid comprising: (a) forming a complex consisting essentially of an antagonist of HCS with the conjugation product of HCS and a tracer; (b) introducing said complex into a sample of biological fluid suspected of containing HCS; and (c) measuring the quantity of tracer which has been set free.
Claim 2
Independent Claim 63 words
A method for quantitatively determining the presence of Human Chorionic Somatotropin (HCS) in a biological fluid comprising: (a) forming a complex consisting essentially of an antagonist of HCS with the conjugation product of HCS and a tracer; (b) introducing said complex into a sample of biological fluid suspected of containing HCS; and (c) measuring the quantity of tracer which has been set free.
Claim 3
Dependent Claim 23 words
The method of claim 1 further comprising fixing the complex to a solid supporting member prior to introducing said complex into said sample.
Claim 4
Dependent Claim 60 words
The method of claim 1 wherein the solid supporting member is selected from the group consisting of cellulose in powder or paper form, cellulose having particular reactive groups as carboxymethyl or diethylaminoethyl in powder or paper form, polyvinyl chloride, polystyrene, nylon, polymethacrylate, polyamide, ureic resins, cellulose acetate, cellulose triacetate, cellulose nitrate, cellulose esters and ethers and derivatives thereof, and glass.
Claim 5
Dependent Claim 29 words
The method of claim 1 wherein the tracer is selected from the group consisting of radioisotopes, fluorescent substances, dyestuffs, enzymes, inhibitors of enzymatic and non-enzymatic reactions and complex-forming agents.
Claim 6
Dependent Claim 40 words
A composition adapted to quantitatively determine the presence of Human Chorionic Somatotropin (HCS) in a biological fluid which comprises a complex of an antagonist of HCS with the conjugation product of HCS and a tracer on a solid supporting member.
Claim 7
Dependent Claim 40 words
A composition adapted to quantitatively determine the presence of Human Chorionic Somatotropin (HCS) in a biological fluid which comprises a complex of an antagonist of HCS with the conjugation product of HCS and a tracer on a solid supporting member.
Claim 8
Dependent Claim 28 words
The composition of claim 5 wherein said tracer is selected from the group consisting of radioisotopes, fluorescent substances, dyestuffs, inhibitors of enzymatic and non-enzymatic reactions, and complex-forming agents.
Claim 9
Dependent Claim 38 words
A merchandising unit comprising containers of substances adapted to quantitatively determine the presence of HCS in a biological fluid formed by the composition of claim 5 and a set of reference standards of HCS having a known concentration.
Claim 10
Dependent Claim 62 words
The merchandising unit of claim 7 wherein the solid supporting member is selected from the group consisting of cellulose in powder or paper form, cellulose having particular reactive groups such as carboxymethyl or diethylaminoethyl in powder or paper form, polyvinyl chloride, polystyrene, nylon, polymethacrylate, polyamide, ureic resins, cellulose acetate, cellulose triacetate, cellulose nitrate, cellulose esters and ethers and derivatives thereof, and glass.

References Cited (Backward Citations)

US4034073A Cited
US4107284A Cited
US4120945A Cited
US4235960A Cited
US4256725A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-06-13 1986-12-13 1987-06-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-06-13 1990-12-13 1991-06-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-06-13 1994-12-13 1995-06-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag